Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Devonian Health Group Inc (DVHGF)

Devonian Health Group Inc (DVHGF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield (Fwd) N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING N/A

Most Recent Stories

More News
Devonian Reports Human Liver-on-a-Chip Data Demonstrating Disease-Relevant Modulation of MASH by Thykamine™, with Dose-Dependent Anti-Fibrotic and Anti-Inflammatory Effects

QUEBEC , Feb. 19, 2026 /PRNewswire/ - Devonian Health Group Inc. ("Devonian" or the Company) (TSXV: GSD) (OTCQB: DVHGF) today announced positive results from a follow-up preclinical study evaluating...

DVHGF : 10.6500 (unch)
GSD.VN : 13.990 (unch)
Devonian Reports Human Liver-on-a-Chip Data Demonstrating Disease-Relevant Modulation of MASH by Thykamine™, with Dose-Dependent Anti-Fibrotic and Anti-Inflammatory Effects

QUEBEC , Feb. 19, 2026 /CNW/ - Devonian Health Group Inc. ("Devonian" or the Company) (TSXV: GSD) (OTCQB: DVHGF) today announced positive results from a follow-up preclinical study evaluating...

DVHGF : 10.6500 (unch)
GSD.VN : 13.990 (unch)
Devonian Advances Thykamine™ Patent Strategy with Proprietary Fingerprint and Robust Manufacturing Controls

QUEBEC , Feb. 17, 2026 /PRNewswire/ - Devonian Health Group Inc. ("Devonian" or the Company) ( TSXV: GSD) (OTCQB: DVHGF) today announced that a proprietary Thykamine™ fingerprint has been...

DVHGF : 10.6500 (unch)
GSD.VN : 13.990 (unch)
Devonian reports additional molecular data from MASH liver study

Gene expression analysis from the STAM mouse model attributes Thykamine™ with dose-dependent anti-MASH, anti-inflammatory and anti-fibrosis molecular effects in liver

DVHGF : 10.6500 (unch)
GSD.VN : 13.990 (unch)
Devonian reports additional molecular data from MASH liver study

Gene expression analysis from the STAM mouse model attributes Thykamine™ with dose-dependent anti-MASH, anti-inflammatory and anti-fibrosis molecular effects in liver

DVHGF : 10.6500 (unch)
GSD.VN : 13.990 (unch)
DEVONIAN REPORTS POSITIVE RESULTS IN PULMONARY FIBROSIS STUDY

QUÉBEC , Feb. 10, 2026 /PRNewswire/ - Devonian Health Group Inc. (" Devonian " or the " Company ") (TSXV: GSD); (OTCQB: DVHGF), a clinical stage corporation focused on developing unique...

DVHGF : 10.6500 (unch)
GSD.VN : 13.990 (unch)
GSD : 11.25 (-0.88%)
DEVONIAN APPOINTS DENNIS TURPIN AS CHIEF FINANCIAL OFFICER AND PROVIDES UPDATES ON STOCK OPTIONS GRANT

QUÉBEC , Feb. 2, 2026 /PRNewswire/ - Devonian Health Group Inc. (" Devonian " or the " Company ") (TSXV: GSD) (OTCQB: DVHGF), a clinical stage corporation focused on developing unique solutions...

DVHGF : 10.6500 (unch)
GSD.VN : 13.990 (unch)
DEVONIAN ANNOUNCES SHARE CONSOLIDATION IN FURTHER PREPARATION FOR POTENTIAL U.S. LISTING

QUÉBEC , Jan. 20, 2026 /PRNewswire/ - Devonian Health Group Inc. (" Devonian " or the " Company ") (TSXV: GSD) (OTCQB: DVHGF) is pleased to announce that, in connection with an evaluation...

DVHGF : 10.6500 (unch)
GSD.VN : 13.990 (unch)
DEVONIAN ANNOUNCES SHARE CONSOLIDATION IN FURTHER PREPARATION FOR POTENTIAL U.S. LISTING

QUÉBEC , Jan. 20, 2026 /CNW/ - Devonian Health Group Inc. (" Devonian " or the " Company ") (TSXV: GSD) (OTCQB: DVHGF) is pleased to announce that, in connection with an evaluation of...

DVHGF : 10.6500 (unch)
GSD.VN : 13.990 (unch)
Devonian Health Group Announces Grant of Stock Options

QUEBEC , Dec. 19, 2025 /CNW/ - Devonian Health Group Inc. (" Devonian " or the " Company ") (TSXV: GSD) (OTCQB: DVHGF), a biopharmaceutical Company specializing in the development of prescription...

DVHGF : 10.6500 (unch)
GSD.VN : 13.990 (unch)

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point N/A
1st Resistance Point N/A
Last Price 10.6500
1st Support Level N/A
2nd Support Level N/A
3rd Support Level N/A

See More

52-Week High 10.6500
Fibonacci 61.8% 10.6500
Fibonacci 50% 10.6500
Fibonacci 38.2% 10.6500
Last Price 10.6500
52-Week Low 10.6500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar